Table 1.
Summarized results as measured by the modified Ensuring Quality Information for Patients tool.
|
|
Gallstone disease score (total=16) | Acute/chronic pancreatitis score (total=19) | Cirrhosis/portal hypertension score (total=15) | Pancreatic ductal adenocarcinoma score (total=17) | Hepatocellular carcinoma score (total=14) | |
| Content Data | ||||||
|
|
Initial definition of which subjects will be covered | 0 | 0 | 0 | 0 | 0 |
|
|
Coverage of the previously defined subjects (N/Aa if the answer is “no” for item 1) | 0 | 0 | 0 | 0 | 0 |
|
|
Description of the medical problem, treatment, or procedure | 1 | 1 | 1 | 1 | 1 |
|
|
Definition of the purpose of the interventions | 1 | 1 | 1 | 0 | 1 |
|
|
Description of treatment alternatives (conservative management) | 0 | 1 | 1 | 1 | 1 |
|
|
Description of the sequence of the interventions and surgical procedure | 0 | 0 | 0 | 1 | 0 |
|
|
Description of the qualitative benefits for the patient | 0 | 1 | 1 | 1 | 1 |
|
|
Description of the quantitative benefits to the patient | 0 | 1 | 1 | 1 | 1 |
|
|
Description of the qualitative risks and complications | 1 | 1 | 0 | 1 | 0 |
|
|
Description of the quantitative risks and complications | 1 | 1 | 1 | 1 | 0 |
|
|
Addressing quality-of-life issues | 1 | 1 | 1 | 1 | 1 |
|
|
Description of how complications are handled | 1 | 1 | 0 | 1 | 1 |
|
|
Description of the precautions that the patient may take | 1 | 1 | 0 | 0 | 1 |
|
|
Mention of alert signs that the patient may detect | 1 | 1 | 1 | 1 | 0 |
|
|
Addressing medical intervention costs and insurance issues | 0 | 1 | 0 | 0 | 0 |
|
|
Specific contact details for hospital services (N/A if not hospitals) | N/A | N/A | N/A | N/A | N/A |
|
|
Specific details of other sources of reliable information/support | 1 | 1 | 1 | 1 | 0 |
|
|
Coverage of all relevant issues for the topic (summary item for all content criteria) | 1 | 1 | 1 | 0 | 1 |
|
|
Total for content data | 10 | 14 | 10 | 11 | 9 |
| Date of issue or revision | ||||||
|
|
Date of issue or revision | 1 | 1 | 1 | 1 | 1 |
|
|
Logo of the issuing body | 0 | 0 | 0 | 0 | 0 |
|
|
Names of the persons or entities that produced the document | 0 | 0 | 0 | 0 | 0 |
|
|
Names of the persons or entities that financed the document | 0 | 0 | 0 | 0 | 0 |
|
|
Short bibliography of the evidence-based data used in the document | 0 | 0 | 0 | 0 | 0 |
|
|
Statement about whether and how patients were involved/consulted in the document’s production | 0 | 0 | 0 | 0 | 0 |
|
|
Total for date of issue or revision | 1 | 1 | 1 | 1 | 1 |
| Structure data | ||||||
|
|
Use of everyday language and explanation of complex words or jargon | 0 | 0 | 0 | 0 | 0 |
|
|
Use of generic names for all medications or products (N/A if no medications described) | 1 | N/A | N/A | 1 | N/A |
|
|
Use of short sentences (<15 words on average) | 0 | 0 | 0 | 0 | 0 |
|
|
Personal address to the reader | 0 | 0 | 0 | 0 | 0 |
|
|
Respectful tone | 1 | 1 | 1 | 1 | 1 |
|
|
Clear information (no ambiguities or contradictions) | 0 | 0 | 0 | 0 | 0 |
|
|
Balanced information on risks and benefits | 1 | 1 | 1 | 1 | 1 |
|
|
Presentation of information in a logical order | 0 | 0 | 0 | 0 | 0 |
|
|
Satisfactory design and layout (excluding figures or graphs; see next item) | 1 | 1 | 1 | 1 | 1 |
|
|
Clear and relevant figures or graphs (N/A if absent) | N/A | N/A | N/A | N/A | N/A |
|
|
Inclusion of a named space for the reader’s notes or questions | 1 | 1 | 1 | 1 | 1 |
|
|
Inclusion of a printed consent form contrary to recommendations (N/A if not from hospitals) | N/A | N/A | N/A | N/A | N/A |
|
|
Total for structure data | 5 | 4 | 4 | 5 | 4 |
aN/A: not applicable.